COMMUNIQUÉS West-GlobeNewswire

Celyad Announces Third Quarter 2017 Business Update
17/11/2017
MONT-SAINT-GUIBERT, Belgium, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris: CYAD ) (NASDAQ: CYAD ), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T [...]
Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
17/11/2017
Company Announcement Genmab to receive milestone payment of USD 50 million in DARZALEX collaboration Milestone triggered by sales of DARZALEX reaching USD 1 billion in a calendar year Copenhagen, Denmark; November 17, [...]
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
17/11/2017
BURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way [...]
Devonian Announces the Filing of New Patent Application for Thykamine™
17/11/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD [...]
Devonian annonce le dépôt d'une nouvelle demande de brevet pour le Thykamine(MC)
17/11/2017
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 16 nov. 2017 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) une société [...]
Karmanos Cancer Institute presents its 2017 Heroes of Cancer
16/11/2017
DETROIT , Nov. 16, 2017 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute presented its 2017 Heroes of Cancer at an awards ceremony held Nov. 15, recognizing champions in 15 award categories: individuals and [...]
NADP Analysis Shows Adults with Medicaid Preventive Dental Benefits Have Lower Medical Costs for Chronic Conditions
16/11/2017
DALLAS, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Recent Medical Expenditure Panel Survey (MEPS) data reveals an opportunity for states to provide both better care for the Medicaid population and potentially reduce the [...]
Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinson’s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D Day
16/11/2017
CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]
Emblem Completes Bought Deal Financing
16/11/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Company ") is pleased [...]
SeaSpine to Participate in the 29th Annual Piper Jaffray Healthcare Conference
16/11/2017
CARLSBAD, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time
16/11/2017
NEW HAVEN, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced it will issue financial results for the Third Quarter ended September 30, 2017 and provide an update on corporate [...]
Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference
16/11/2017
CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]
Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting
16/11/2017
GERMANTOWN, Md., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that data from the Company’s Phase [...]
Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
16/11/2017
MENLO PARK, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Ascendis Pharma A/S Reports Third Quarter 2017 Financial Results
16/11/2017
- Phase 3 Program for TransCon Growth Hormone Advances and TransCon PTH Enters the Clinic - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S [...]
VBL Therapeutics Announces Proposed Public Offering of 2.5 Million Shares of Ordinary Shares
16/11/2017
TEL AVIV, Israel, Nov. 16, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Asterias Biotherapeutics to Present at Piper Jaffray Healthcare Conference on November 28, 2017
16/11/2017
FREMONT, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Michael Mulroy, President and [...]
Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test
16/11/2017
BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix ® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better than the established [...]
Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran
16/11/2017
VANCOUVER, B.C. and WARMINSTER, Pa., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that the [...]

Pages